Nektar Therapeutics (NKTR)
37.22
-1.43
(-3.70%)
USD |
NASDAQ |
Oct 23, 16:00
37.23
+0.01
(+0.03%)
After-Hours: 20:00
Nektar Therapeutics Price to Book Value : 1.407 for Oct. 23, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 23, 2026 | 1.407 |
| October 22, 2026 | 1.461 |
| October 21, 2026 | 1.446 |
| October 20, 2026 | 1.482 |
| October 19, 2026 | 1.385 |
| October 16, 2026 | 1.352 |
| October 15, 2026 | 1.426 |
| October 14, 2026 | 1.394 |
| October 13, 2026 | 1.433 |
| October 12, 2026 | 1.506 |
| October 09, 2026 | 1.556 |
| October 08, 2026 | 1.542 |
| October 07, 2026 | 1.522 |
| October 06, 2026 | 1.508 |
| October 05, 2026 | 1.596 |
| October 02, 2026 | 1.647 |
| October 01, 2026 | 1.776 |
| September 30, 2026 | 2.288 |
| September 29, 2026 | 2.239 |
| September 28, 2026 | 2.283 |
| September 25, 2026 | 2.156 |
| September 24, 2026 | 2.244 |
| September 23, 2026 | 2.179 |
| September 22, 2026 | 2.304 |
| September 21, 2026 | 2.526 |
| Date | Value |
|---|---|
| September 18, 2026 | 2.536 |
| September 17, 2026 | 2.583 |
| September 16, 2026 | 2.546 |
| September 15, 2026 | 2.518 |
| September 14, 2026 | 2.589 |
| September 11, 2026 | 2.636 |
| September 10, 2026 | 2.670 |
| September 09, 2026 | 2.771 |
| September 08, 2026 | 2.851 |
| September 04, 2026 | 2.804 |
| September 03, 2026 | 2.886 |
| September 02, 2026 | 2.749 |
| September 01, 2026 | 2.712 |
| August 31, 2026 | 2.698 |
| August 28, 2026 | 2.741 |
| August 27, 2026 | 2.817 |
| August 26, 2026 | 2.788 |
| August 25, 2026 | 2.833 |
| August 24, 2026 | 2.785 |
| August 21, 2026 | 2.797 |
| August 20, 2026 | 2.817 |
| August 19, 2026 | 2.875 |
| August 18, 2026 | 2.783 |
| August 17, 2026 | 2.746 |
| August 14, 2026 | 2.760 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Eli Lilly & Co. | 35.39 |
| Inovio Pharmaceuticals, Inc. | 16.90 |
| Tonix Pharmaceuticals Holding Corp. | 0.3906 |
| Capricor Therapeutics, Inc. | 1.400 |
| Kyntra Bio, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 16.54 |
| PEG Ratio | -0.0415 |
| Price | 37.22 |
| Earnings Yield | -17.99% |
| Market Cap | 1.270B |
| PEGY Ratio | -0.0415 |